A Study of TQC3927 Powder for Inhalation in Healthy Adult Subjects

Summary

This is a dose escalation trial. The dosing regimen involves a single-dose study. This is a single-center, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability and pharmacokinetic characteristics of TQC3927 powder for inhalation in healthy adults subjects.

Timeline

Start

2024-05-22

Primary completion

2024-08-19

Completion

2024-08-19

Drugs

Indications